Imunon, Inc. Announces Virtual Annual Meeting of Stockholders on June 12, 2024
Ticker: IMNN · Form: DEF 14A · Filed: Apr 26, 2024 · CIK: 749647
Sentiment: neutral
Topics: Imunon, Annual Meeting, Proxy Statement, Virtual Meeting, Stockholders
TL;DR
<b>Imunon, Inc. is holding its 2024 Annual Meeting of Stockholders virtually on June 12th, featuring director elections, auditor ratification, and executive compensation votes.</b>
AI Summary
Imunon, Inc. (IMNN) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Imunon, Inc. will hold its Annual Meeting of Stockholders virtually on June 12, 2024, at 10:00 a.m. Eastern Time. The virtual format is adopted to expand access, improve communications, and reduce costs for stockholders, the Company, and the environment. The meeting agenda includes the election of two Class II Directors, ratification of WithumSmith+Brown PC as independent auditors for FY2024, and an advisory vote on 2023 executive compensation. Stockholders can attend, vote, and submit questions via webcast at www.virtualshareholdermeeting.com/IMNN2024. The company was formerly known as Celsion Corp and Cheung Laboratories Inc.
Why It Matters
For investors and stakeholders tracking Imunon, Inc., this filing contains several important signals. The shift to a virtual meeting format aims to increase stockholder participation globally and mitigate health risks, potentially leading to broader engagement and feedback. Key proposals include electing directors and ratifying the auditor, which are standard governance procedures that signal the company's ongoing operational and financial oversight.
Risk Assessment
Risk Level: low — Imunon, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks disclosed.
Analyst Insight
Stockholders should review the proposals regarding director elections and executive compensation before the June 12th meeting.
Key Numbers
- June 12, 2024 — Annual Meeting Date (Date of the Annual Meeting of Stockholders.)
- 10:00 a.m. Eastern Time — Annual Meeting Time (Time of the Annual Meeting of Stockholders.)
- 2027 — Director Term End (Year until Class II Directors will serve.)
- 2024 — Fiscal Year End (Fiscal year for which the independent auditor is being ratified.)
- 2023 — Executive Compensation Year (Year for which executive compensation is subject to advisory vote.)
Key Players & Entities
- Imunon, Inc. (company) — Registrant and filer of the proxy statement.
- June 12, 2024 (date) — Date of the Annual Meeting of Stockholders.
- WithumSmith+Brown PC (company) — Proposed independent registered public accounting firm.
- 2023 (date) — Fiscal year for which executive compensation is being voted on.
- Celsion Corp (company) — Former name of Imunon, Inc.
- Cheung Laboratories Inc (company) — Former name of Imunon, Inc.
FAQ
When did Imunon, Inc. file this DEF 14A?
Imunon, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 26, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Imunon, Inc. (IMNN).
Where can I read the original DEF 14A filing from Imunon, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Imunon, Inc..
What are the key takeaways from Imunon, Inc.'s DEF 14A?
Imunon, Inc. filed this DEF 14A on April 26, 2024. Key takeaways: Imunon, Inc. will hold its Annual Meeting of Stockholders virtually on June 12, 2024, at 10:00 a.m. Eastern Time.. The virtual format is adopted to expand access, improve communications, and reduce costs for stockholders, the Company, and the environment.. The meeting agenda includes the election of two Class II Directors, ratification of WithumSmith+Brown PC as independent auditors for FY2024, and an advisory vote on 2023 executive compensation..
Is Imunon, Inc. a risky investment based on this filing?
Based on this DEF 14A, Imunon, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks disclosed.
What should investors do after reading Imunon, Inc.'s DEF 14A?
Stockholders should review the proposals regarding director elections and executive compensation before the June 12th meeting. The overall sentiment from this filing is neutral.
Risk Factors
- Election of Directors [low — regulatory]: Two Class II Directors are to be elected to serve until the Annual Meeting of Stockholders in 2027.
- Ratification of Independent Auditor [low — regulatory]: The selection of WithumSmith+Brown PC as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2024, is to be ratified.
- Executive Compensation Vote [low — regulatory]: An advisory vote will be held to approve the 2023 executive compensation for the Company’s Named Executive Officers.
Key Dates
- 2024-06-12: Annual Meeting of Stockholders — Key date for voting on corporate matters and electing directors.
Glossary
- DEF 14A
- Definitive Proxy Statement filed with the SEC. (Indicates the filing is a final proxy statement for shareholder voting.)
- Named Executive Officers
- Top executive compensation recipients within a company. (Relevant for the advisory vote on executive compensation.)
- Class II Directors
- Directors elected for a specific term, typically three years. (Relevant for the election of directors at the annual meeting.)
Filing Stats: 4,702 words · 19 min read · ~16 pages · Grade level 11.3 · Accepted 2024-04-26 06:10:40
Key Financial Figures
- $0.01 — ers who own our common stock, par value $0.01 per share, as of the close of business
Filing Documents
- formdef14a.htm (DEF 14A) — 439KB
- 0001493152-24-016044.txt ( ) — 440KB
From the Filing
DEF 14A 1 formdef14a.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 IMUNON, INC. (Name of Registrant as Specified in its Charter) N/A (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. IMUNON, INC. 997 LENOX DRIVE, SUITE 100 LAWRENCEVILLE, NJ 08648 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD VIRTUALLY ON WEDNESDAY, JUNE 12, 2024 AT 10:00 A.M., EASTERN TIME To Our Stockholders: Notice is hereby given that the annual meeting (the “Annual Meeting”) of the stockholders of IMUNON, INC., a Delaware corporation (the “Company”), will be held at 10:00 a.m., local time, on Wednesday, June 12, 2024. You will be able to attend the Annual Meeting, vote, and submit your questions during the meeting via live webcast through the link www.virtualshareholdermeeting.com/IMNN2024 and entering your 16-digit control number included on the notice of Internet availability of the proxy materials, on your proxy card or in the instructions that accompanied your proxy materials. We have adopted a virtual meeting format to expand access to the meeting, improve communications and impose lower costs on our stockholders, the Company and the environment. We believe virtual meetings enable increased stockholder participation from locations around the world. This format allows us to continue to proceed with the meeting while mitigating the potential health and safety risks to participants. The Annual Meeting shall be held for the following purposes, all as more fully described in the accompanying Proxy Statement: 1) To elect two Class II Directors to serve until the Annual Meeting of Stockholders in 2027 or until their successors are duly elected and qualified; 2) To ratify the selection of WithumSmith+Brown PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024; 3) To approve, by a non-binding advisory vote, the 2023 executive compensation for the Company’s Named Executive Officers; and 4) To consider and act upon any other matters that may properly come before the Annual Meeting and any adjournment or postponement thereof. The close of business on April 19, 2024 has been fixed as the record date for the determination of stockholders of the Company entitled to notice of, and to vote at the Annual Meeting. Only stockholders of record at the close of business on April 19, 2024 are entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. All stockholders are cordially invited to attend the Annual Meeting. However, whether or not you expect to attend via the live webcast, please complete, sign, date and return the enclosed Proxy Card as promptly as possible in the envelope provided for that purpose. Returning your Proxy Card will ensure your representation and help to ensure the presence of a quorum at the Annual Meeting. Your proxy is revocable, as set forth in the accompanying Proxy Statement. Therefore, you may attend the Annual Meeting and vote your shares via the live webcast even if you send in your Proxy Card. By Order of the Board of Directors /s/ Michael H. Tardugno April 26, 2024 Lawrenceville, NJ Michael H. Tardugno Executive Chairman YOUR VOTE IS IMPORTANT THIS PROXY STATEMENT IS FURNISHED IN CONNECTION WITH THE SOLICITATION OF PROXIES BY THE COMPANY, ON BEHALF OF THE BOARD OF DIRECTORS, FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS. THE PROXY STATEMENT AND THE RELATED PROXY FORM ARE BEING DISTRIBUTED ON OR ABOUT MAY 5, 2024. YOU CAN VOTE YOUR SHARES USING ONE OF THE FOLLOWING METHODS: COMPLETE AND RETURN A WRITTEN PROXY CARD ATTEND THE COMPANY’S 2024 ANNUAL MEETING OF STOCKHOLDERS VIA LIVE WEBCAST AND VOTE AT THE ANNUAL MEETING VOTE VIA THE INTERNET AT WWW.PROXYVOTE.COM VOTE BY PHONE BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING VOTING DOCUMENT ALL STOCKHOLDERS ARE CORDIALLY INVITED TO ATTEND THE MEETING. HOWEVER, TO ENSURE YOUR REPRESENTATION AT THE MEETING, YOU ARE URGED TO COMPLETE, SIGN, DATE AND RETURN THE ACCOMPANYING PROXY CARD AS PROMPTLY AS POSSIBLE IN THE POSTAGE-PREPAID ENVELOPE ENCLOSED FOR THAT PURPOSE OR SUBMIT YOUR VOTE VIA THE INTERNET AT WWW.PROXYVOTE.COM OR VOTE BY PHONE BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING VOTING DOCUMENT. ANY S